A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
ConditionHealthy Volunteers (HV)
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorJade Biosciences, Inc.
About this trial
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.
Eligibility criteria
Qualifiers
Healthy male or female participants 18-55 years of age, inclusive
First-generation Japanese or Chinese participants born in Japan/China
A body weight between 40-100 kg and a body mass index (BMI) between 18.0 - 32.0 kg/m2 (all inclusive) at screening
Willing and able to comply with the study site stay, scheduled visits, and study procedures
Disqualifiers
Harmful alcohol use
Smoking/vaping or heavy tobacco use within 2 years prior to screening
Known history of abuse of illicit drugs
Nursing, lactating or pregnant, or who have plans to become pregnant during the study
Trial design
Treatments tested in this trial
- JADE101
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov